Dendrimer enhanced irinotecan (Starpharma)
伊立替康树枝状聚合物 (Starpharma)
Report date: 2024/08/21 17:46:08
Base Information
Drug NameDendrimer enhanced irinotecan (Starpharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesStarpharma Pty Ltd
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A